CSL Behring

csl.com · King of Prussia, United States of America

CSL Behring is a global biotechnology company that develops and manufactures plasma-derived and recombinant therapies to treat rare and serious medical conditions, including bleeding disorders, immune deficiencies, and respiratory diseases. It serves hospitals, clinics, and specialty pharmacies worldwide, generating revenue through the sale of its biotherapeutic products and related services. CSL Behring operates as a subsidiary of CSL Limited, focusing on research, development, and large-scale production of specialty biologics.

Revenue
$1B+
Employees
5,001+
Founded
1904
Headquarters
King of Prussia, United States of America

CSL Behring customers on Arbolus

Total customers 23 22 current · 1 former
Reviews growth 8 new reviews since May 2026

Customers who reviewed CSL Behring

Seniority of CSL Behring customers

Most people who reviewed CSL Behring hold C-Suite roles (61%), followed by Director (33%) and Manager (6%).

  • C-Suite 61%
  • Director 33%
  • Manager 6%

Customers sample

Other Generalist Not specified NPS 6 Will renew
Other Partner Not specified NPS 10
People Generalist Director NPS 9 Will renew

Employer names and spend open in the full report, along with the other 19 customers.

What 22 Arbolus experts think of CSL Behring

Overall sentiment: Positive

The NPS distribution for CSL Behring is weighted toward the positive, with multiple experts rating 8–10 and only one recording a '0' (outlier). Most experts with renewal intent are committed to continuing, particularly those in mature or multi-year implementations. Stickiness is high among established users, with a minority in the offboarding stage. Key themes from expert feedback include product reliability, integration, and dependable support. Negative feedback centers on budget constraints and competitive platform threats.

Everything 22 customers told us about CSL Behring.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

40 Net Promoter Score, from 22 scored reviews
  • Promoters 12
  • Passives 7
  • Detractors 3

Praised

  • Workflow Integration and Reliability
  • Stable Budget Allocation
  • Customer Support Strength
  • Educational and Operational Support

Criticised

  • Competitive Platform Strength
  • Reimbursement Environment Changes
  • Supply Chain Disruptions
  • Potential for Competitive Displacement

What CSL Behring customers say

Workflow Integration and Reliability

“I found CSL Behring’s solution improved our workflow reliability and reduced administrative burdens, which was vital for consistent operational efficiency.”

Other Generalist · Information Technology · 10,000+ employees · North America

Stable Budget Allocation

“A consistent portion of my annual budget is allocated to CSL Behring due to their therapies’ predictable use and reliable product performance.”

Other Generalist · Information Technology · 10,000+ employees · North America

Customer Support Strength

“The strength of customer support and clarity of clinical information made CSL Behring stand out in our vendor selection process.”

Other Generalist · Information Technology · 10,000+ employees · North America

Renewal intent

Plan to renew 63%
  • Will renew 12
  • Undecided 4
  • Not renewing 3

Plan to renew, by seniority

  • C-Suite 67% 9 answers
  • Director 50% 6 answers
  • Not specified 75% 4 answers
  • 8.7/10 Average score from customers who will renew
  • 7.5/10 Average score from undecided customers
  • 6.3/10 Average score from customers not renewing

Top alternatives

Most weighed by CSL Behring customers

Report

Oct 2026 23 + 0

For people who use CSL Behring

Do you use CSL Behring at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 22 customers of CSL Behring have already contributed

Takes a few minutes. Your identity stays anonymous.